Klin Onkol 1992; 5(2): 59.
Authors: Novotný L., Balážová E., Rauko P., Reichlová Věra1992-04-15:Synergism of Cis-DDP and ARA-C
Authors: Novotný L., Balážová E., Rauko P., Reichlová Věra1992-04-15:Synergism of Cis-DDP and ARA-C
Klin Onkol 1992; 5(2): 59.
Authors: Balážová E., Novotný L., Tejc P., Ujházy V.1992-04-15:Cyclocytidine and its effect on Zajdela hepatoma cells
Authors: Balážová E., Novotný L., Tejc P., Ujházy V.1992-04-15:Cyclocytidine and its effect on Zajdela hepatoma cells
Klin Onkol 1992; 5(2): 60.
Authors: Bizzari J. P., Khayat D.1992-04-15:Current development of the nitrosourea fotemustine: results and perspectives
Authors: Bizzari J. P., Khayat D.1992-04-15:Current development of the nitrosourea fotemustine: results and perspectives
Klin Onkol 1992; 5(2): 60.
Authors: Vachálková A., Novotný L.1992-04-15:Electrochemical study on new cytotoxic nucleoside analogs
Authors: Vachálková A., Novotný L.1992-04-15:Electrochemical study on new cytotoxic nucleoside analogs
Klin Onkol 1992; 5(2): 60.
Keywords: cytokine research
Authors: Micksche Michael1992-04-15:Clinical aspects of cytokine research
Keywords: cytokine research
Authors: Micksche Michael1992-04-15:Clinical aspects of cytokine research
Klin Onkol 1992; 5(2): 60.
Authors: Bizzari J. P., Khayat D.1992-04-15:Current development of the nitrosourea fotemustine: results and perspectives
Authors: Bizzari J. P., Khayat D.1992-04-15:Current development of the nitrosourea fotemustine: results and perspectives
Klin Onkol 1992; 5(2): 61.
Authors: Jacob M., Rowe M.D.1992-04-15:Clinical use of hemopoietic growth factors
Authors: Jacob M., Rowe M.D.1992-04-15:Clinical use of hemopoietic growth factors
Klin Onkol 1992; 5(2): 61.
Authors: Koza (1954 - 2012) Vladimír, Pittrová Helena, Šlechtová J., Vozobulová Věra, Pavlíčková Jaroslava1992-04-15:The risk of alloimmunization during the intensive postremission therapy of acute leukemias
Authors: Koza (1954 - 2012) Vladimír, Pittrová Helena, Šlechtová J., Vozobulová Věra, Pavlíčková Jaroslava1992-04-15:The risk of alloimmunization during the intensive postremission therapy of acute leukemias
Klin Onkol 1992; 5(2): 61.
Authors: Koza (1954 - 2012) Vladimír, Šlechtová J., Šifaldová T.1992-04-15:Cephalothin, Azlocillin and Tobramycin as front-line therapy for febrile patients with severe granulocytopenia
Authors: Koza (1954 - 2012) Vladimír, Šlechtová J., Šifaldová T.1992-04-15:Cephalothin, Azlocillin and Tobramycin as front-line therapy for febrile patients with severe granulocytopenia
Klin Onkol 1992; 5(2): 62.
Authors: Klastersky (Jan Klasterský) Jean1992-04-15:Empiric therapy for febrile neutropenia
Authors: Klastersky (Jan Klasterský) Jean1992-04-15:Empiric therapy for febrile neutropenia
Klin Onkol 1992; 5(2): 62.
Authors: Body Jean-Jacques1992-04-15:Place of bisphosphonates in the management of cancer hypercalcemia and bone metastases
Authors: Body Jean-Jacques1992-04-15:Place of bisphosphonates in the management of cancer hypercalcemia and bone metastases
Klin Onkol 1992; 5(2): 63.
Authors: Schwarz Jiří, Stöckbauer Petr, Lukášová Marie, Vaňásek Jaroslav1992-04-15:Retinoic acid (RA) in the treatment of leukemia - Experimental background and clinical experience
Authors: Schwarz Jiří, Stöckbauer Petr, Lukášová Marie, Vaňásek Jaroslav1992-04-15:Retinoic acid (RA) in the treatment of leukemia - Experimental background and clinical experience
Klin Onkol 1992; 5(2): 63.
Authors: Kolaric K., Županc D.1992-04-15:Local application of tetrachlorode-caoxygen anion complex (Oxoferin) in patients with tissue necrosis caused by cytostatic extravasation
Authors: Kolaric K., Županc D.1992-04-15:Local application of tetrachlorode-caoxygen anion complex (Oxoferin) in patients with tissue necrosis caused by cytostatic extravasation
Klin Onkol 1992; 5(2): 64.
1992-04-15:Information of medicaments
1992-04-15:Information of medicaments
Klin Onkol 1992; 5(1): 4-10.
Keywords: Radiochemotherapy, hyperfractionation, linear-quadratic model, the interdigitated alternating regimen, scoring and grading system of toxicity of combined treatment, Lonidamin
Authors: Jurga Ľudovít1992-02-15:Current possibilities of the radiochemotherapy optimalization from the point of view of tumour answer and toxicity by combined therapy
Keywords: Radiochemotherapy, hyperfractionation, linear-quadratic model, the interdigitated alternating regimen, scoring and grading system of toxicity of combined treatment, Lonidamin
Authors: Jurga Ľudovít1992-02-15:Current possibilities of the radiochemotherapy optimalization from the point of view of tumour answer and toxicity by combined therapy
